|Articles|November 18, 2003
Corneal collagen crosslinking safely halts keratoconus progression
Crosslinking of corneal collagen by topical treatment with riboflavinand ultraviolet light exposure shows promise as a safe and effective nonsurgicaltreatment for keratoconus, according to data presented by Theo Seiler, MD,PhD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Post-hoc AREDS2 analysis highlights distinct mechanisms driving GA progression
2
Sight Sciences reports new data supporting long-term efficacy of OMNI Surgical System
3
Retina experts reflect on how OCT transformed patient care
4
AAO 2025: 12-month outcomes of travoprost intracameral implant (iDose TR) in conjunction with cataract surgery
5















































.png)


